Collegium Pharmaceutical Stock Overlap Studies Kaufman Adaptive Moving Average

COLL Stock  USD 30.38  0.04  0.13%   
Collegium Pharmaceutical overlap studies tool provides the execution environment for running the Kaufman Adaptive Moving Average study and other technical functions against Collegium Pharmaceutical. Collegium Pharmaceutical value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Kaufman Adaptive Moving Average study function is designed to identify and follow existing trends. Collegium Pharmaceutical overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Time Period to run this model.

The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Kaufman Adaptive Moving Average allows the user to define Collegium Pharmaceutical range across which they want the smoothing.

Collegium Pharmaceutical Technical Analysis Modules

Most technical analysis of Collegium Pharmaceutical help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Collegium from various momentum indicators to cycle indicators. When you analyze Collegium charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Collegium Pharmaceutical Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Collegium Pharmaceutical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Collegium Pharmaceutical based on widely used predictive technical indicators. In general, we focus on analyzing Collegium Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Collegium Pharmaceutical's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Collegium Pharmaceutical's intrinsic value. In addition to deriving basic predictive indicators for Collegium Pharmaceutical, we also check how macroeconomic factors affect Collegium Pharmaceutical price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.07480.0721
Price To Sales Ratio1.831.74
Hype
Prediction
LowEstimatedHigh
27.7730.1532.53
Details
Intrinsic
Valuation
LowRealHigh
28.6531.0333.41
Details
Naive
Forecast
LowNextHigh
27.4529.8432.22
Details
5 Analysts
Consensus
LowTargetHigh
30.4933.5037.19
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Technical Analysis Now

   

Technical Analysis

Check basic technical indicators and analysis based on most latest market data
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Banking Idea
Banking
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Momentum Idea
Momentum
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Impulse Idea
Impulse
Invested few shares
Investing Idea
Investing
Invested few shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
Millennials Best Idea
Millennials Best
Invested few shares
When determining whether Collegium Pharmaceutical is a strong investment it is important to analyze Collegium Pharmaceutical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Collegium Pharmaceutical's future performance. For an informed investment choice regarding Collegium Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collegium Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.49)
Earnings Share
2.34
Revenue Per Share
18.538
Quarterly Revenue Growth
0.165
Return On Assets
0.0968
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.